Complainant part is not expected to be returned for manufacturer review/investigation.The investigation could not be completed; no conclusion could be drawn, as no product was received.Based on the information available, it has been determined that no corrective and/or preventative action is proposed.This complaint will be accounted for and monitored via post market surveillance activities.If additional information is made available, the investigation will be updated as applicable.Device was used for treatment, not diagnosis.If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.
|
Device report from synthes reports an event in (b)(6) as follows: it was reported that on (b)(6) 2021, the patient underwent the open reduction internal fixation surgery for trimalleolar fracture of distal tibia with guide wire in question.Cannulated cancellous screw fixation was planned.During the procedure the surgeon drilled the back malleolus from the front, while the guide wire broke and remained in patient's body.The surgeon was not successful to take out the broken wire from patient's body and tried for over 15(fifteen) minutes.Procedure was completed successfully with 30(thirty) minutes of delay.This report is for one (1) 1.25mm threaded guide wire 150mm.This is report 1 of 1 for complaint (b)(4).
|
Depuy synthes is submitting this report pursuant to the provisions of 21 cfr, part 803.This report may be based on information which depuy synthes has not been able to investigate or verify prior to the required reporting date.This report does not reflect a conclusion by fda, depuy synthes or its employees that the report constitutes an admission that the device, depuy synthes, or its employees caused or contributed to the potential event described in this report.If the information is unknown, not available or does not apply, the section/field of the form is left blank.H10 additional narrative: h3, h4, h6: sterile: part #: 292.620s; lot #: 7l97591; manufacturing site: selzach; supplier: (b)(4); release to warehouse date: 17 mar 2021; expiration date: 01 mar 2031.A manufacturing record evaluation was performed for the finished device lot number, and no non-conformances were identified.Non-sterile: part #: 292.620; lot #: 93p5543.Sterile part: part #: 292.620s; lot #: 7l90978; manufacturing site: selzach; supplier: (b)(4); release to warehouse date: 01 mar 2021; expiration date: 01 mar 2031.A manufacturing record evaluation was performed for the finished device lot number, and no non-conformances were identified.Non-sterile: product code: 292.620; lot #: 88p1822.Product#292.620; lot#93p5543 and 88p1822; manufacturing site: balsthal; release to warehouse 17.Feb2021and9.Mar2021.A manufacturing record evaluation was performed for the finished device 292.620 lot# 88p1822 and 93p5543 and no non-conformance was identified product was not returned.Based on the information available, it has been determined that no corrective and preventative action is proposed.This complaint will be accounted for and monitored via post market surveillance activities.If additional information is made available, the investigation will be updated as applicable.Device was used for treatment, not diagnosis.If information is obtained that was not available for the initial medwatch, a follow-up medwatch will be filed as appropriate.
|